Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations - Wikidata - awgldk - TriplyDB

Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations

Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations

http://www.wikidata.org/entity/Q35527336

about

Connecting molecular pathways to hereditary cancer risk syndromes High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma Paragangliomas/Pheochromocytomas: clinically oriented genetic testing Pheochromocytoma in a Twelve-Year-Old Girl with SDHB-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study Oxygen concentration controls epigenetic effects in models of familial paraganglioma.Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty.cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted?Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.Familial pheochromocytomas and paragangliomas.Structured assessment and followup for patients with hereditary kidney tumour syndromes.Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.Update on pediatric cancer predisposition syndromes.Malignant paraganglioma of the rectum: the first case report and a review of the literature.Pathophysiology and diagnosis of disorders of the adrenal medulla: focus on pheochromocytoma.Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations.Outcomes of Patients with Metastatic Phaeochromocytoma and Paraganglioma: a Systematic Review and Meta-analysis.Update on Modern Management of Pheochromocytoma and Paraganglioma.Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas.Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.Malignant Pheochromocytoma and Paraganglioma: 272 Patients over 55 Years.An unusual case of gastrointestinal bleeding.Review of Pediatric Pheochromocytoma and Paraganglioma.Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.Malignant paraganglioma in children treated with embolization prior to surgical excision.Tianeptine interferes with microtubule organization and hormone secretion of pheochromocytoma cells.And the GIST is: When one has a GIST, think of an association!Succinate dehydrogenase (SDH)-deficient neoplasia.New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population.Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.Sporadic paraganglioma caused by de novo SDHB mutations in a 6-year-old girl.Radiological Surveillance Screening in Asymptomatic Succinate Dehydrogenase Mutation Carriers.

P2860

Q28291516-C64F8BF7-7797-49D4-BFFD-CABD82A976C7 Q28541862-AA0B26BD-5C20-4964-AAD7-E85AA11E64CD Q33679204-F9E377D4-5CF4-41F2-B307-8CB757DB9D11 Q34145968-71007E56-63DC-4C14-853E-C3300266CF2F Q34410500-22740C4D-2D18-4C90-985B-81B7B1774686 Q34469783-9BFC2C00-33E6-4839-88BD-4501F8901021 Q35620433-81EAEE58-2EF3-447C-93D8-97F057E7F8CB Q36458386-7E8CFE0A-593F-4ED2-A1E2-AB19921ECD71 Q36477785-D1C20533-F24A-408D-B632-1424976DCBEA Q36763148-CDD0F31B-321C-48D8-91D3-957547C7B5AA Q37165294-7A0442B0-AD90-418C-89E4-2E30161BABCD Q37202015-D1EBE306-32E9-4D9F-91F7-51EC9FC70807 Q37568369-8FAC2D06-8AE9-44B2-AB78-59EDED1098C6 Q37666156-4148D2AC-0FB1-4F68-858D-89E8729506CB Q37969708-05A2BFB6-92CF-4E20-96CC-F5267F4A7C4B Q38102639-D70AC304-A45E-4B9C-8BAC-05BD418DF526 Q38168830-1A7D24B0-00F9-4887-B4D8-5FCE5A7DBB22 Q38203226-B804D430-AB3C-4097-847A-1EC89E389F66 Q38266745-B4E50BB0-A307-4CA7-84C9-C5376B9659E2 Q38267933-D2E47088-E87A-4923-ACE2-60404280030F Q38659956-DD897FE1-6B2F-4039-ABD5-A5B14EAD7084 Q38661522-E08EF1FC-0675-4EE7-925F-983A90A312D9 Q38831451-A8411261-351F-4973-8DD4-24085F8E2086 Q38857083-8F539B42-5D5D-4527-8A01-888A18D4861C Q38890111-F410B0E7-F848-4051-9BB7-4213B2435A50 Q39171991-C038B343-A2F5-495A-BCB6-0A164304B31C Q39366984-59684E77-6AA6-4878-A8CC-A9B3DC87CA30 Q40339465-7481AB63-E50B-4E41-8A57-D6E50368695F Q40999640-50E7D78F-D61A-4574-A9D0-AC15F9DE4225 Q41207387-8499EE16-FAF5-4F7E-85AA-BAA2472B9083 Q42257590-56781525-3101-4E13-88B1-18BCBAA57505 Q42670989-F43C3377-F96F-4EFA-8C77-478BD172ED63 Q44525870-46A95A34-474A-49FD-A587-D2844099A94F Q47680883-729E54F5-0C88-4B59-B4D9-652175C2DFD1 Q47934716-DB9C02C5-B308-4172-8D03-84565A6420B6 Q49174438-1894B911-B1DD-418E-9820-522E06A9A7AB Q50076749-8B0E1B95-A0D0-4310-8210-19CDD6FED839 Q50201225-424B013F-0413-48DC-BE74-FCBC5C377ED2 Q50569615-17EBE2BC-8145-4118-9AA2-28C47239571C Q55078471-A24055B7-9F12-4080-A40D-E094756CB395

P2860

Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations

http://www.wikidata.org/entity/Q35527336

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Metastatic pheochromocytoma/pa ...... ificant link to SDHB mutations

@ast

Metastatic pheochromocytoma/pa ...... ificant link to SDHB mutations

@en

type

label

Metastatic pheochromocytoma/pa ...... ificant link to SDHB mutations

@ast

Metastatic pheochromocytoma/pa ...... ificant link to SDHB mutations

@en

prefLabel

Metastatic pheochromocytoma/pa ...... ificant link to SDHB mutations

@ast

Metastatic pheochromocytoma/pa ...... ificant link to SDHB mutations

@en

P1433

Q35527336-9BA15358-6B59-4169-8EBC-230F4B12796A

P1476

Q35527336-8AC4E89A-E822-458A-84DA-5B3A39DD56AB

P2093

Q35527336-10040FBB-1663-4B80-B8F5-B92266742E35

Q35527336-5D5ED348-DF39-43E2-86DA-5468BD3ECD54

Q35527336-7D7612E7-CA76-4C2E-88E3-190B6A02E086

Q35527336-85B0DA2F-9811-4B23-8F12-8EE444125163

Q35527336-A7A7BF81-FA99-4AF1-A089-A9287B0D5557

Q35527336-B62D29BD-408C-48A2-9654-32BC4D72948A

Q35527336-D6019487-E7F5-4717-BED2-01A40E9E99DE

Q35527336-F7945413-0969-4E6E-ABC2-9DF3D270D4FD

Q35527336-FA03FB8D-22A3-4828-837D-E5CF13055003

Q35527336-FAD9D14A-A743-4EE9-B440-16971F9E8CB7

P2860

Q35527336-042F2F38-6C65-44C5-9108-CA6C8327000B

Q35527336-0B5D2E3F-DBDF-4940-A483-88EBD2A7BC21

Q35527336-17D24109-5753-4849-8D24-FA72AB7F796A

Q35527336-1FBACE51-F8BD-4151-A817-717E76B67E05

Q35527336-2282B2FF-5836-4546-8187-030BC8AE02DA

Q35527336-247DCC75-E842-43AC-8460-66673170E53B

Q35527336-2BCAEC19-BF18-4FB1-B512-579092268218

Q35527336-2EA5127C-F2FF-4A04-9DF2-ECEDFB82AFC9

Q35527336-3B0AAD28-B79E-4C4A-B883-A19C372155A8

Q35527336-3C7BAB24-3334-4602-AAE2-DCA55EFBA648

P304

Q35527336-89FDEC6E-485A-413B-8DC4-0BD16374D4F9

P31

Q35527336-15FD64F2-E664-4D27-9801-37458FF6E0F6

P356

Q35527336-FB1245B0-9AB7-4A4A-B77F-74100366C488

P407

Q35527336-E4796D06-DAD0-48AF-A201-C63AD3B389CF

P433

Q35527336-904F3B5C-6B91-484F-9A01-BB018923B706

P478

Q35527336-7475CD9A-73D6-4E88-B42F-EA74F4C05C67

P50

Q35527336-7D737CA6-53FB-47E6-8528-124CC447EACF

Q35527336-A2665591-88D6-4E30-9E83-FC64790222B4

Q35527336-B841F39D-92C0-4325-A703-CF257B07082E

Q35527336-F09CF85F-C94B-456A-BC6F-582A2833ED1A

P577

Q35527336-F2159E7B-6578-4A9A-9E9C-56171E2618FF

P5875

Q35527336-B0FA1833-8713-4CD2-A06E-D4FE1AF42572

P698

Q35527336-9C97CD02-D37A-4EC0-A9FB-BDF7A004351A

P921

Q35527336-5753B78A-553F-46D1-9CD8-5643A6A47B06

Q35527336-8B667737-BB5E-48B9-8E0D-46380B410692

P932

Q35527336-E72727F3-A29F-41B0-B892-5EBD52644FD4

P356

JCO.2011.34.6353

P1433

Journal of Clinical Oncology

P1476

Metastatic pheochromocytoma/pa ...... ificant link to SDHB mutations

@en

P2093

Dragana Milosevic

http://www.w3.org/2001/XMLSchema#string

Electron Kebebew

http://www.w3.org/2001/XMLSchema#string

Graeme Eisenhofer

http://www.w3.org/2001/XMLSchema#string

Kathryn S King

http://www.w3.org/2001/XMLSchema#string

Margaret Zacharin

http://www.w3.org/2001/XMLSchema#string

Margarita Raygada

http://www.w3.org/2001/XMLSchema#string

Maya Lodish

http://www.w3.org/2001/XMLSchema#string

Robert Wesley

http://www.w3.org/2001/XMLSchema#string

Shana McCormack

http://www.w3.org/2001/XMLSchema#string

Tamara Prodanov

http://www.w3.org/2001/XMLSchema#string

P2860

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma

High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing

Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma

The Warburg effect is genetically determined in inherited pheochromocytomas

A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma.

SDHA is a tumor suppressor gene causing paraganglioma.

Pheochromocytoma. Special considerations in children.

SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.

P304

4137-4142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2011.34.6353

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Jacqueline K. Hewitt

Anne-Paule Gimenez-Roqueplo

Constantine A Stratakis

P577

2011-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51691158

http://www.w3.org/2001/XMLSchema#string

P698

21969497

http://www.w3.org/2001/XMLSchema#string

P921

phaeochromocytoma

P932

3208535

http://www.w3.org/2001/XMLSchema#string